https://www.123articleonline.com/rss/author/281012/stella-wilsonArticles written by Stella Wilson from 123ArticleOnline.comen-usCopyright (c) 123ArticleOnline.com All rights reserved. https://www.123articleonline.com/articles/1187332/antibody-contract-manufacturing-market-analysis-and-forecast-to-2030 The 'Antibody Contract Manufacturing Market, 2020-2030' report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies. https://www.123articleonline.com/articles/1187198/antibody-contract-manufacturing-market-analysis-opportunities-trends-and-industry-strategies-2019 Several companies worldwide claim to possess the required expertise and infrastructure to offer contract manufacturing services for a variety of antibody-based products https://www.123articleonline.com/articles/1186484/antibody-contract-manufacturing-market-size-share-trends-demand-by-2030 The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well https://www.123articleonline.com/articles/1186499/biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-over-usd-139-billion-by-20 Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages https://www.123articleonline.com/articles/1187391/biopharmaceutical-contract-manufacturing-market-research-report-2019-2030 The 'Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 - 2030' report features an extensive study on the contract service providers within the biopharmaceutical industry. https://www.123articleonline.com/articles/1186725/biopharmaceutical-contract-manufacturing-market-size-share-growth-analysis-and-forecast-to-2030 The Biopharmaceutical Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030 https://www.123articleonline.com/articles/1185187/cell-and-advanced-therapies-supply-chain-management-market-headed-for-growth-and-global-expansion-by Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 https://www.123articleonline.com/articles/1185797/cell-and-advanced-therapies-supply-chain-management-market-overview-by-2030 The 'Cell and Advanced Therapies Supply Chain Management Market, 2020-2030' report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced therapies. https://www.123articleonline.com/articles/1185504/cell-and-advanced-therapies-supply-chain-management-market-forecast-to-2030 Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies https://www.123articleonline.com/articles/1186754/cell-therapy-manufacturing-market-analysis-opportunities-trends-and-industry-strategies-2019-2030 The Cell Therapy Manufacturing Market is projected to grow at an annualized rate of >16.5%, till 2030 https://www.123articleonline.com/articles/1187238/cell-therapy-manufacturing-market-headed-for-growth-and-global-expansion-by-2030 More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis https://www.123articleonline.com/articles/1187404/cell-therapy-manufacturing-market-research-report-2019-2030 More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis https://www.123articleonline.com/articles/1186519/cell-therapy-manufacturing-market-research-report-forecast-to-2030-roots-analysis Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers https://www.123articleonline.com/articles/1188753/computer-aided-drug-discovery-services-market-research-report-2019-2030 The process of drug development, beginning from the discovery of a pharmacological lead to its commercial launch, is estimated to take around 10-15 years, involving capital investments in the range of USD 4-10 billion. https://www.123articleonline.com/articles/1186540/continuous-manufacturing-market-forecast-to-2030 The Continuous Manufacturing Market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1186094/drug-delivery-systems-market-research-report-by-2030 More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis https://www.123articleonline.com/articles/1187728/global-human-microbiome-based-products-market-2019-2030 Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis https://www.123articleonline.com/articles/1188191/global-in-silico-drug-discovery-services-market-2019-2030 In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis https://www.123articleonline.com/articles/1186325/global-medical-device-label-contract-manufacturing-market-deep-analysis-2019-2030 More than 80 companies presently claim to have the required expertise to design and manufacture different types of labels, using both conventional and advanced printing methods, for use in medical devices, claims Roots Analysis https://www.123articleonline.com/articles/1185352/global-targeted-protein-degradation-market-deep-analysis-2019-2030 The Targeted Protein Degradation Market is projected to grow at an annualized rate of more than 30% till 2030 https://www.123articleonline.com/articles/1186358/global-targeted-protein-degradation-market-report-forecast-by-development-trends-and-forecast-201 The 'Targeted Protein Degradation Market, 2020-2030' report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade. https://www.123articleonline.com/articles/1187539/human-microbiome-based-products-market-size-share-trends-market-growth-global-analysis-and-indus Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis https://www.123articleonline.com/articles/1187553/in-silico-drug-discovery-services-market-is-expected-to-grow-at-a-cagr-156-by-2030 In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis https://www.123articleonline.com/articles/1185274/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-is-projected-to-reach-usd-21-billion Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access https://www.123articleonline.com/articles/1185560/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-research-report-forecast-to-2030-r The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%, till 2030 https://www.123articleonline.com/articles/1186035/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-forecast-to-2030 Nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world https://www.123articleonline.com/articles/1185480/medical-device-label-contract-manufacturing-market-headed-for-growth-and-global-expansion-by-2030 Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs, while focusing on the core aspects of product development https://www.123articleonline.com/articles/1186072/medical-device-label-contract-manufacturing-market-is-expected-to-grow-at-a-cagr-98-by-2030 The Medical Device Label Contract Manufacturing market is projected to grow at an annualized rate of ~9.8%, till 2030 https://www.123articleonline.com/articles/1185663/medical-device-label-contract-manufacturing-market-research-report-2019-2030 The Medical Device Label Contract Manufacturing Market is projected to grow at an annualized rate of ~9.8%, till 2030 https://www.123articleonline.com/articles/1187573/neoantigen-targeted-therapies-market-research-report-forecast-to-2030-roots-analysis The Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1188765/neoantigen-targeted-therapies-market-size-share-trends-demand-by-2030 The 'Neoantigen Targeted Therapies Market, 2019-2030' report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. https://www.123articleonline.com/articles/1188544/neoantigens-market-forecast-to-2030 Presently, over 150 Neoantigen Targeted Therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration https://www.123articleonline.com/articles/1187146/next-generation-immune-checkpoint-inhibitors-and-stimulators-market-size-share-growth-analysis-an The Next Generation Immune Checkpoint Inhibitors And Stimulators Market is projected to grow at an annualized rate of ~15%, till 2030 https://www.123articleonline.com/articles/1186649/next-generation-immune-checkpoint-inhibitors-and-stimulators-market-forecast-to-2030 The Next Generation Immune Checkpoint Inhibitors and Stimulators Market is estimated to be worth USD 12.5 billion in 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1187321/next-generation-immune-checkpoint-modulators-market-forecast-to-2030 More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications, claims Roots Analysis https://www.123articleonline.com/articles/1186300/non-invasive-cancer-diagnostics-market-analysis-opportunities-trends-and-industry-strategies-2019 The 'Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers' report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. https://www.123articleonline.com/articles/1188570/oligonucleotide-synthesis-modification-and-purification-services-market-headed-for-growth-and-globa More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis https://www.123articleonline.com/articles/1187667/oligonucleotide-synthesis-modification-and-purification-services-market-size-by-2030 The Oligonucleotide Synthesis, Modification and Purification Services Market is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1187711/ophthalmic-drugs-contract-manufacturing-market-research-report-forecast-to-2030-roots-analysis The Ophthalmic Drugs Contract Manufacturing Market is projected to grow at an annualized rate of ~8%, till 2030 https://www.123articleonline.com/articles/1188589/ophthalmic-drugs-contract-manufacturing-market-forecast-to-2030 The 'Ophthalmic Drugs Contract Manufacturing Market, 2020-2030' report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs (including ophthalmic drops, emulsions, gels, injections, lotions, ointments, suspensions, and tablets / capsules) - Roots Analysis https://www.123articleonline.com/articles/1186122/protein-degradation-market-forecast-to-2030 More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts https://www.123articleonline.com/articles/1185699/subcutaneous-biologic-drugs-and-affiliated-technologies-market-size-share-trend-growth-forecast The Subcutaneous Biologic Drugs And Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030 https://www.123articleonline.com/articles/1185309/subcutaneous-biologics-technologies-and-drug-delivery-systems-market-trends-2019-2030 Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals https://www.123articleonline.com/articles/1188803/synthesis-modification-and-purification-services-market-research-report-2019-2030 The 'Oligonucleotide Synthesis, Modification and Purification Services Market, Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030' report features a detailed study of the current scenario and future potential of the custom synthesis, modification and purification services market for oligonucleotides, which are intended for research, diagnostic, and therapeutic applications. https://www.123articleonline.com/articles/1185751/target-protein-degradation-market-size-share-trend-growth-forecast-to-2030 More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts